Schreiner develops medication adherence technology
Schreiner MediPharm has partnered with Aardex Group, an expert in digital medication adherence, to develop electronic technology for medication adherence monitoring during clinical trials. According to Schreiner, up to 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen, resulting in distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects. Ultimately, these adverse events can delay time to market. Schreiner's therapy monitoring technology consists of Smart Blister Packs for tablets and Smart Kit Boxes f...
Source: labelsandlabeling.com